A Combination of Retinoic Acid and Proteasome Inhibitors for the Treatment of Leukemias Is Potentially Dangerous-Reference-Cited by-同舟云学术

A Combination of Retinoic Acid and Proteasome Inhibitors for the Treatment of Leukemias Is Potentially Dangerous

Published:1999-09-01 Issue:5 Volume:94 Page:1827-1828
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Wójcik Cezary¹,Młynarczuk Izabella²,Hoser Graz˙yna³,Kawiak Jerzy³,Stokłosa Tomasz⁴,Gołab Jakub⁴,Wilk Sherwin⁵

Affiliation:

1. Department of Histology and Embryology; Institute of Biostructure; Medical University of Warsaw; Warsaw, Poland

2. Department of Histology and Embryology; Department of Immunology; Institute of Biostructure; Medical University of Warsaw; Warsaw, Poland

3. Department of Clinical Cytology; Postgraduate Center of Medical Instruction; Warsaw, Poland

4. Department of Immunology; Institute of Biostructure; Medical University of Warsaw; Warsaw, Poland

5. Department of Pharmacology; Mount Sinai Medical Center; New York, NY

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/94/5/1827/1657066/1827.pdf

Reference10 articles.

1. Constitutive degradation of PML/RARα through the proteasome pathway mediates retinoic acid resistance.;Fanelli;Blood,1999

2. Targeting protein breakdown to treat cancer.;Bonn;Molec Med Today,1999

3. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis.;Delic;Br J Cancer,1998

4. Apoptosis induced in L1210 leukemia cells by an inhibitor of the chymotrypsin-like activity of the proteasome.;Wojcik;Apoptosis,1997

5. Comparison of the level of cellular retinoid-binding proteins and susceptibility to retinoid-induced growthinhibition of various neoplastic cell lines.;Lotan;J Nat Cancer Inst,1980

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Proteasome Is Required for Rapid Initiation of Death Receptor-Induced Apoptosis;Molecular and Cellular Biology;2006-03

2. The Proteasome: A Novel Therapeutic Target in Haematopoietic Malignancy;Hematology;2003-10

3. Regulation of apoptosis by the ubiquitin and proteasome pathway;Journal of Cellular and Molecular Medicine;2002-01

4. Proteasome inhibitors as anti-cancer agents;Anti-Cancer Drugs;2000-07

5. Ubiquitin- and proteasome-dependent pathway of protein degradation as an emerging therapeutic target;Emerging Therapeutic Targets;2000-02